International Stem Cell Corp. (ISCO)

[lookingforprofit]

Thanks for the response. Yes dilution is always a concern for these type companies. The "lifeline" products seem to be offsetting some of the need to raise capital but it seems doubtful that part of the business will grow quickly enough to supply all of their future needs. If this is a reasonable premise then at what point/ time would you see another stock offering ?

Thanks again for your help